Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Racial Disparity in Drug Utilization Among Multiple Myeloma Patients: A SEER Medicare Analysis

Sikander Ailawadhi, MD, Ryan D Frank, MS, Richa Menghani, MD, Mayank Sharma, MBBS, M'hamed Temkit, Shumail M. Paulus, MBBS, Nandita Khera, MD, Shahrukh K. Hashmi, MD, Pooja Advani, MBBS, Abhisek Swaika, MBBS, Aneel Paulus, MD MS, Vivek Roy, MD, Gerardo Colon-Otero, MD, Asher A. Chanan-Khan, MD

Blood (2016) 128 (22): 3542.

https://doi.org/10.1182/blood.V128.22.3542.3542

Published: 2016

Journal Articles

Trends in Disease Presentation, Management, Cost of Care and Outcomes: A Comprehensive Look at Racial Disparities in Multiple Myeloma (MM)

Sikander Ailawadhi, MD, Ryan D Frank, MS, Mayank Sharma, MBBS, Richa Menghani, MD, M'hamed Temkit, Shumail M. Paulus, MBBS, Nandita Khera, MD, Shahrukh K. Hashmi, MD, Pooja Advani, MBBS, Abhisek Swaika, MBBS, Aneel Paulus, MD, Nabeel Aslam, MD, Vivek Roy, MD, Gerardo Colon-Otero, MD, Asher A. Chanan-Khan, MD

Blood (2016) 128 (22): 3544.

https://doi.org/10.1182/blood.V128.22.3544.3544

Published: 2016

Journal Articles

Phase I/II Clinical Trial of Lenalidomide in Combination with AT101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Aneel Paulus, MDMS, Pooja Advani, MBBS, Betsy R. Laplant, MS, Sharoon Akhtar, MPhil, Taimur Sher, MD, Candido E. Rivera, MD, James M. Foran, MD, Vivek Roy, MD, Gerardo Colon-Otero, MD, Sikander Ailawadhi, MD, Asher Alban Chanan-Khan, MD

Blood (2015) 126 (23): 5299.

https://doi.org/10.1182/blood.V126.23.5299.5299

Published: 2015

Journal Articles

Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma

Aneel Paulus, MDMS, Sharoon Akhtar, MPhil, Kelara Samuel, Hassan Yousaf, Davitte Cogen, Pooja Advani, MBBS, Thomas E. Witzig, MD, George J Weiner, MD, Sikander Ailawadhi, MD, Joachim Gullbo, MD PhD, Stig Linder, PhD, Geraldo Otero-Colon, Kasyapa S. Chitta, PhD, Asher Alban Chanan-Khan, MD

Blood (2015) 126 (23): 1557.

https://doi.org/10.1182/blood.V126.23.1557.1557

Published: 2015

Journal Articles

Current State of Patient Awareness and Participation in Care for Multiple Myeloma and the Psychophysical Impact of Treatment: An International Internet-Based Study

Sikander Ailawadhi, MD, Abhisek Swaika, MBBS, Pooja Advani, MBBS, Michael S Katz, David O Hodge, Aneel Paulus, MDMS, Nandita Khera, MD MPH, Shahrukh K Hashmi, MD, Gerardo Colon-Otero, MD, Vivek Roy, MD, Asher Chanan-Khan, MD

Blood (2014) 124 (21): 1294.

https://doi.org/10.1182/blood.V124.21.1294.1294

Published: 2014

Journal Articles

Behavioral Patterns and the Role of Ethnicity in Patient Awareness of Multiple Myeloma and the Psychophysical Impact of Its Treatment

Pooja Advani, MBBS, Abhisek Swaika, MBBS, Denice D. Tsao-Wei, PhD, Ahsan Alamgir, Brian Chung, Christine Duran, Susan Groshen, PhD, Savrina Bola, Asher Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2014) 124 (21): 2622.

https://doi.org/10.1182/blood.V124.21.2622.2622

Published: 2014

Journal Articles

BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy

Sulada Pukiat, MD, Nuttapong Ngamphaiboon, MD, Pooja Advani, MBBS, Julio Chavez, MD, George Deeb, MD, Anjana Elefante, Pharm, D, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2010) 116 (21): 3130.

https://doi.org/10.1182/blood.V116.21.3130.3130

Published: 2010

Journal Articles

The Expression of Bcl-6 In Diffuse Large B Cell Lymphoma (DLBCL) Is Associated with Improved Progression Free Survival and Overall Survival Following Front-Line Rituximab-Chemotherapy

Pooja Advani, MBBS, Nuttapong Ngamphaiboon, MD, Sulada Pukiat, MD, Julio Chavez, MD, George Deeb, MD, Anjana Elefante, Pharm, D, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2010) 116 (21): 5073.

https://doi.org/10.1182/blood.V116.21.5073.5073

Published: 2010

NARROW

Racial Disparity in Drug Utilization Among Multiple Myeloma Patients: A SEER Medicare Analysis

Trends in Disease Presentation, Management, Cost of Care and Outcomes: A Comprehensive Look at Racial Disparities in Multiple Myeloma (MM)

Phase I/II Clinical Trial of Lenalidomide in Combination with AT101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma

Current State of Patient Awareness and Participation in Care for Multiple Myeloma and the Psychophysical Impact of Treatment: An International Internet-Based Study

Behavioral Patterns and the Role of Ethnicity in Patient Awareness of Multiple Myeloma and the Psychophysical Impact of Its Treatment

BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy

The Expression of Bcl-6 In Diffuse Large B Cell Lymphoma (DLBCL) Is Associated with Improved Progression Free Survival and Overall Survival Following Front-Line Rituximab-Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only